Postoperative Patient Comfort and Quality of Micturition in Suprapubic Tube vs. Transurethral Catheterization After RARP (MPH)
Prostate Cancer
About this trial
This is an interventional treatment trial for Prostate Cancer focused on measuring urinary drainage, urethral catheter, suprapubic tube, pain, discomfort, radical prostatectomy, robotic surgery, urinary infection
Eligibility Criteria
Inclusion Criteria:
- Minimum age of 18 Years
- Voluntarily agreement to participate in this study
- filled in and signed Informed Consent
- release of medical records for regulatory or research purposes
- clinically organ-confined prostate cancer
- recommended and planned robot-assisted radical prostatectomy
Exclusion Criteria:
- Participation in other interventional trials that could interfere with the present study
- International Prostate Symptom Score (IPPS) > 18
- History of radiation or chemotherapy
- History of transurethral prostate resection
- unable to provide informed consent
- unwillingness to storage and forwarding of pseudonymous data
Sites / Locations
- Department of Urology, Pediatric Urology and Urologic Oncology, St. Antonius Hospital Gronau
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Active Comparator
suprapubic tube ex 2 day
suprapubic tube ex 5 day
transurethral catheter ex 5 day
patients who underwent robot-assisted radical prostatectomy and got intraoperatively, a suprapubic tube, which was withdrawn on the 2th day after the surgery
patients who underwent robot-assisted radical prostatectomy and got intraoperatively, a suprapubic tube, which was withdrawn on the 5th day after the surgery
patients who underwent robot-assisted radical prostatectomy and got intraoperatively, a transurethral catheter, which was withdrawn on the 5th day after the surgery